Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 76 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
751 14.0 months Metastatic colorectal cancer 4 Chemotherapy
Infermi Hospital Italy 5/2002
Treatment Details: Patients: This Phase II trial, involved 45 patients with metastatic colorectal cancer. Most patients (62%) had only one metastatic site. Treatment: Treatment consisted of the bolus admin
 
752 14.0 months metastatic breast cancer 4 Chemotherapy
Medical Research Council Clinical Trials Unit United Kingdom 11/2005
Treatment Details: Patients: This Phase III study involved 705 women (median age 54) with advanced breast cancer with metastases in bone, liver, lung, lymph nodes, and other tissues. Ninety-five women had rec
 
753 14.0 months Stage III NSCLC 5 Chemotherapy
Radiation
Mayo Clinic and Mayo Foundation United States 10/2002
Treatment Details: Patients: This Phase III study involved 234 patients with stage III non-small-cell lung cancer. Patients were divided into two groups: Group A (117 patients) and Group B (117 patients).
 
754 14.0 months Metastatic renal cell carcinoma 4 Immunotherapy
Institut Bergonie France 12/2002
Treatment Details: Patients: This Phase II study involved 66 patients with metastatic renal cell carcinoma, 51 men and 15 women. The median age was 58. Fifty-nine patients had a prior nephrectomy. Treatme
 
755 14.0 months Metastatic renal cell carcinoma 3 Chemotherapy
Immunotherapy
Institut Bergonie France 12/2003
Treatment Details: Patients: This Phase II study involved 35 patients with metastatic renal cell carcinoma; 27 men and 8 women. The median age was 62. All patients had received prior immunotherapy and their
 
756 14.0 months Recurrent epithelial ovarian cancer and fallopian tube or primary peritoneal cancer 5 Biologic therapy
Chemotherapy
M.D. Anderson Cancer Center United States 6/2014
Treatment Details: Patients: This phase 2 study involved previously treated, persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma patients who were divided into two separ
 
757 14.0 months Hepatocellular carcinoma 5 Biologic therapy
Radiation
Taipei Medical University Hospital Taiwan Region 4/2014
Treatment Details: Patients: This phase 2 study involved 40 hepatocellular carcinoma patients with a median age of 60 years; 31 were male. Treatment: Patients were treated with radiation therapy and the b
 
758 14.0 months HER2-positive metastatic breast cancer 3 Biologic therapy
Dana-Farber Cancer Institute United States 6/2012
Treatment Details: Patients: This phase 2 study involved 41 female, HER2-positive metastatic breast cancer patients who had been previously treated with trastuzumab. The median patient age was 54 years. T
 
759 14.0 months Peripheral T-cell lymphoma patients 4 Chemotherapy
Hormone
Shanghai Jiao Tong University School of Medicine China 6/2013
Treatment Details: Patients: This study involved 31 elderly (60 years or older) refractory and relapsed peripheral T-cell lymphoma patients who had previously received chemotherapy. The median patient age wa
 
760 14.0 months Platinum resistant ovarian cancer and Primary peritoneal carcinomatosis 4 Biologic therapy
Chemotherapy
Indiana University United States 12/2011
Treatment Details: Patients: This phase II study involved 14 women with ovarian cancer or primary peritoneal carcinomatosis who had received prior platinum-based chemotherapy. The median patient age was 52.5
 
Page 76 of 187  | Previous Page  | Next Page